BioSyent (OTCMKTS:BIOYF) Shares Up 0.9% – Still a Buy?

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report) shares were up 0.9% on Wednesday . The stock traded as high as $10.7415 and last traded at $10.7415. Approximately 208 shares changed hands during mid-day trading, a decline of 91% from the average daily volume of 2,352 shares. The stock had previously closed at $10.65.

BioSyent Trading Down 1.7%

The firm has a fifty day simple moving average of $10.97 and a 200 day simple moving average of $9.58.

BioSyent Company Profile

(Get Free Report)

BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.

BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.

See Also

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.